Japan Nuclear Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The market is segmented by Product and Application

Japan Nuclear Imaging Industry Overview

Japan nuclear imaging market
Study Period: 2018 - 2028
CAGR: 6.85 %

Major Players

 Japan nuclear imaging market growth

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Japan Nuclear Imaging Market Analysis

Japan Nuclear Imaging market is expected to witness a CAGR of 6.85% during the forecast period. Certain factors that are driving the market growth include the rise in prevalence of cancer and cardiac disorders, increase in technological advancements, growth in the applications of nuclear medicine and imaging.

After being ranked the topmost cause of life-loss in the last century, stroke is now the third-ranked cause of death in Japan, following cancer and heart disease. According to the 2018 article, “Lifestyle and cardiovascular disease in Japan”, the recent trend of rising CHD (coronary heart disease) prevalence among the urban population is a cause for serious concern, as a potential source of forthcoming problems for public health as well as clinical practice in Japan. Moreover, due to the association between lifestyle and CVD (cardiovascular disease), higher sodium, lower calcium, and lower animal protein content in the diet, along with higher alcohol consumption, may account for the higher prevalence of hypertension and higher risk of stroke in the Japanese population than for western population at same BMI levels. According to the latest OECD data, in Japan, patients with end-stage kidney failure (ESKF), often caused by diabetes and hypertension, are the highest in the OECD at 238 per 100,000 population while the average is 101. Thus, the increasing prevalence of cancer, along with certain cardiovascular diseases, is expected to propel the growth of the nuclear imaging market in Japan.

Japan Nuclear Imaging Industry Segments

Nuclear medicine imaging procedures are non-invasive and, with the exception of intravenous injections, are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers.

Report scope can be customized per your requirements. Click here.

Japan Nuclear Imaging Market Trends

This section covers the major market trends shaping the Japan Nuclear Imaging Market according to our research experts:

Single Photon Emission Computed Tomography Equipment is Expected to Hold a Significant Market Share

As per the scope of the report, SPECT equipment includes planar scintigraphy, stand-alone SPECT, hybrid SPECT/CT equipment along with radioisotopes delivery systems, etc. SPECT significantly differs from other types of radiologic and tomographic imaging modalities, such as CT scan or conventional radiography. In SPECT, rather than passing x-rays through a patient to form an image, the patient is injected with a radiopharmaceutical which then emits radiation in the form of gamma rays or x-rays, which are detected by a gamma camera. Advances in image processing algorithms, innovations in radionuclide and ligands, and the advent of multi-modality imaging systems are driving the market growth for modern SPECT and SPECT/CT devices.

Japan nuclear imaging market share

Japan Nuclear Imaging Market Competitor Analysis

The Japan Nuclear Imaging market is moderately competitive and consists of a few major players. Companies like ATOX CO. Ltd, Bracco Imaging SpA, CANON INC., Fujifilm (FUJIFILM Toyama Chemical Co. Ltd), GE HEALTHCARE, IBA Radiopharma Solutions, JFE Engineering Corporation, Koninklijke Philips NV, Nihon Medi-Physics Co. (Sumitomo Chemical Co. Ltd), Siemens Healthineers, among others, hold the substantial market share in the Japan Nuclear Imaging market.

Japan Nuclear Imaging Market Top Players

  1. Bracco Imaging SpA


  3. Fujifilm (FUJIFILM Toyama Chemical Co. Ltd)

  4. GE Healthcare

  5. ATOX

*Disclaimer: Major Players sorted in no particular order

ATOX CO. Ltd, Bracco Imaging SpA, CANON INC., Fujifilm,  GE HEALTHCARE,  IBA Radiopharma Solutions,  JFE Engineering Corporation,  Koninklijke Philips NV

Japan Nuclear Imaging Market Report - Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Prevalence of Cancer and Cardiac Disorders

      2. 4.2.2 Increase in Technological Advancements

      3. 4.2.3 Growth in the Applications of Nuclear Medicine and Imaging

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Techniques

      2. 4.3.2 Short Half-life of Radiopharmaceuticals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Product

      1. 5.1.1 Equipment

      2. 5.1.2 Radioisotope

        1. SPECT Radioisotopes

          1. Technetium-99m (TC-99m)

          2. Thallium-201 (TI-201)

          3. Gallium (Ga-67)

          4. Iodine (I-123)

          5. Other SPECT Radioisotopes

        2. PET Radioisotopes

          1. Fluorine-18 (F-18)

          2. Rubidium-82 (RB-82)

          3. Other PET Radioisotopes

    2. 5.2 Application

      1. 5.2.1 SPECT Applications

        1. Orthopedics

        2. Thyroid

        3. Cardiology

        4. Other SPECT Applications

      2. 5.2.2 PET Applications

        1. Oncology

        2. Cardiology

        3. Neurology

        4. Other PET Applications


    1. 6.1 Company Profiles

      1. 6.1.1 ATOX CO. Ltd

      2. 6.1.2 Bracco Imaging SpA

      3. 6.1.3 CANON INC.

      4. 6.1.4 Fujifilm (FUJIFILM Toyama Chemical Co. Ltd)

      5. 6.1.5 GE HEALTHCARE

      6. 6.1.6 IBA Radiopharma Solutions

      7. 6.1.7 JFE Engineering Corporation

      8. 6.1.8 Koninklijke Philips NV

      9. 6.1.9 Nihon Medi-Physics Co. (Sumitomo Chemical Co. Ltd)

      10. 6.1.10 Siemens Healthineers

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Japan Nuclear Imaging Market Research FAQs

The Japan Nuclear Imaging Market is studied from 2018 - 2028.

The Japan Nuclear Imaging Market is growing at a CAGR of 6.85% over the next 5 years.

Bracco Imaging SpA, CANON INC., Fujifilm (FUJIFILM Toyama Chemical Co. Ltd), GE Healthcare, ATOX are the major companies operating in Japan Nuclear Imaging Market.

Japan Nuclear Imaging Industry Reports

In-depth industry statistics and market share insights of the Japan Nuclear Imaging sector for 2020, 2021, and 2022. The Japan Nuclear Imaging research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the Japan Nuclear Imaging report PDF.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!